NFKB1 and urinary bladder carcinoma: Finally, to support the notion that miR-130b maintains NF-κB activity by decreasing CYLD expression, we overexpressed or knocked down the expression of miR-130b in bladder cancer cells, and we confirmed the activation or suppression of NF-κB signaling, respectively.